Insider Transactions in Q4 2025 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,839
-21.12%
|
-
|
|
Dec 29
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,667
+32.29%
|
-
|
|
Dec 29
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-0.22%
|
-
|
|
Dec 29
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.55%
|
-
|
|
Dec 29
2025
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,786
-0.16%
|
-
|
|
Dec 29
2025
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,334
+0.63%
|
-
|
|
Dec 29
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+26.53%
|
-
|
|
Dec 29
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+1.26%
|
-
|
|
Dec 29
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,369
-4.14%
|
-
|
|
Dec 29
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+10.44%
|
-
|
|
Dec 29
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.35%
|
-
|
|
Dec 29
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-1.07%
|
-
|
|
Dec 29
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+2.65%
|
-
|
|
Dec 29
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+0.27%
|
-
|
|
Dec 12
2025
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
26,746
-53.46%
|
$615,158
$23.33 P/Share
|
|
Dec 12
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.73%
|
$100,000
$5.78 P/Share
|
|
Dec 08
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.28%
|
-
|
|
Dec 08
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,669
-3.2%
|
-
|
|
Dec 08
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,855
+11.61%
|
-
|
|
Dec 08
2025
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,534
+0.09%
|
-
|
|
Dec 08
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+13.43%
|
-
|
|
Dec 08
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,492
-20.76%
|
-
|
|
Dec 08
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,039
+40.11%
|
-
|
|
Dec 08
2025
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+27.25%
|
-
|
|
Dec 08
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.37%
|
-
|
|
Dec 08
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,873
+1.09%
|
-
|
|
Dec 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-1.15%
|
-
|
|
Dec 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,067
+2.85%
|
-
|
|
Dec 01
2025
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
135,000
-1.05%
|
-
|
|
Nov 26
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,983
-73.49%
|
$252,609
$23.33 P/Share
|
|
Nov 26
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,983
+42.36%
|
$43,932
$4.21 P/Share
|
|
Nov 21
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,641
-29.29%
|
-
|
|
Nov 21
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,603
+50.0%
|
-
|
|
Nov 21
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,030
-0.86%
|
-
|
|
Nov 21
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,161
+2.14%
|
-
|
|
Nov 21
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+0.19%
|
-
|
|
Nov 21
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,872
-3.19%
|
-
|
|
Nov 21
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,006
+7.5%
|
-
|
|
Nov 21
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+10.96%
|
-
|
|
Nov 21
2025
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,775
+0.04%
|
-
|
|
Nov 21
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+0.25%
|
-
|
|
Nov 21
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-22.41%
|
-
|
|
Nov 21
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,894
+38.33%
|
-
|
|
Nov 21
2025
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+28.64%
|
-
|
|
Nov 21
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,267
+0.77%
|
-
|
|
Nov 21
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,364
-2.92%
|
-
|
|
Nov 21
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,603
+10.72%
|
-
|
|
Nov 12
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Open market or private sale
|
Direct |
40,000
+14.76%
|
$880,000
$22.7 P/Share
|